Heart Group of the Eastern Shore

What Heart Group of the Eastern Shore does

Heart Group of the Eastern Shore is a privately held, single-location cardiology practice headquartered at 4 Medical Park Drive, Fairhope, Alabama, serving Baldwin County and the broader Eastern Shore region of coastal Alabama. Founded in 2006, the practice employs 11-50 staff and operates with three board-certified cardiologists (Dr. Michael S. Pursley, Dr. Glenn Harris, Dr. Andrew J. Moses) and three advanced practice providers (Elizabeth Key PA-C, Michael Charles NP-C, Savannah Gilbert NP-C). The group delivers full-stack ambulatory cardiology including echocardiography, stress testing, Holter/event monitoring, nuclear cardiology, vascular ultrasound, calcium score testing, cardiac PET/CT, coronary CT arteriography, preventive cardiovascular care, hypertension and cholesterol management, pacemaker follow-up, and left heart catheterization, all performed on-site at the Fairhope location. A 24-hour coverage relationship with Thomas Hospital secures inpatient cardiology volume and post-discharge referrals, and the practice differentiates itself by offering same-day and next-day appointment availability against typical multi-week cardiology wait times.

The practice generates fee-for-service patient care revenue billed through insurance (Medicare/Medicaid and private payers) and operates a wholly-owned clinical research subsidiary, Eastern Shore Research Institute (ESRI), which conducts Phase I-IV cardiovascular clinical trials. ESRI runs 10+ active trials sponsored by AstraZeneca, Amgen, Pfizer, Novo Nordisk, Regeneron, Boehringer Ingelheim, DalCor Pharmaceuticals, Cytokinetics, New Amsterdam Pharma, and Bayer, with ESRI contributing patient recruitment, study coordination, regulatory compliance, data accuracy/reporting, and study monitoring services. Patient-facing digital infrastructure is built on Athenahealth for patient portal access and online bill payment. Go-to-market is direct-to-consumer for patient care, supplemented by Thomas Hospital inpatient referrals and ESRI-driven clinical trial enrollment, with marketing executed through the practice website, Facebook, and physician referral networks. No external funding, M&A activity, or institutional ownership has been disclosed; the practice is physician-owned and operated.

Name

Heart Group of the Eastern Shore

Legal name

Heart Group of the Eastern Shore

Website

https://heartgroupes.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Heart Group of the Eastern Shore is a privately held cardiology practice in Fairhope, Alabama, providing on-site diagnostic imaging, chronic cardiovascular disease management, and Phase I-IV clinical trial services through its ESRI subsidiary to Baldwin County patients and pharmaceutical sponsors.

Ownership category

akta.pro rank

Product category

Cardiology Services

NAICS

Diagnostic Imaging Centers (621512), Offices of Other Health Practitioners (6213)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Cardiology (Consultative) (HLAKABAA)

akta.pro secondary industries

Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE), Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE)

Keywords

• Cardiology services
• Diagnostic imaging
• Heart disease management
• Clinical research
• Preventive cardiology

Headquarters

HQ city

Fairhope

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Patient Care Services: Fee-for-service healthcare revenue generated from cardiology consultations, diagnostic testing, and ongoing cardiovascular disease management. Services billed to insurance including Medicare/Medicaid and private payers.
2. Clinical Research: Revenue from conducting clinical trials for pharmaceutical sponsors (Phase I-IV). Includes patient recruitment, study coordination, data collection, and regulatory compliance services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Heart Group of the Eastern Shore is a private cardiology practice providing comprehensive cardiovascular care including diagnostic imaging (echocardiograms, stress testing, Holter/event monitoring, nuclear cardiology, cardiac PET/CT, vascular ultrasound, calcium score testing, coronary CT arteriography), preventive cardiology, chronic condition management (hypertension, cholesterol, heart rhythm disorders, pacemaker follow-up), and invasive procedures (left heart catheterization). The practice also operates a clinical research subsidiary, Eastern Shore Research Institute (ESRI), conducting Phase I-IV cardiovascular clinical trials for pharmaceutical sponsors.

Product overview

Heart Group of the Eastern Shore is a cardiology practice providing comprehensive heart care services in Fairhope, Alabama. The practice operates as a unified offering combining diagnostic services (Echocardiogram, Stress Testing, Holter & Event Monitoring, Nuclear Cardiology, Vascular Ultrasound, Calcium Score Testing, Cardiac PET/CT, Coronary CT Arteriography), preventive and chronic condition management (Cardiovascular Disease Prevention, Hypertension & Cholesterol Management, Pacemaker Follow-Up Care, Left Heart Catheterization), and patient engagement tools (Patient Portal via Athenahealth, Online Bill Payment). A distinct subsidiary, Eastern Shore Research Institute (ESRI), conducts Phase I-IV clinical trials and offers services including the 30-Second Screening tool for patient recruitment, alongside regulatory compliance, data reporting, and study coordination. The practice emphasizes same-day and next-day appointments with most testing performed on-site.

Differentiator

Problem solved

Functional benefit

Products and services

• Echocardiogram Non-invasive ultrasound that creates detailed images of the heart's structure and function to detect valve problems, heart muscle weakness, and other conditions. For patients with suspected structural heart disease or cardiomyopathy.
• Stress Testing Evaluates how the heart performs during physical activity or controlled stress to reveal blood flow issues or irregular rhythms in a supervised environment. For patients with suspected coronary artery disease or exercise-related symptoms.
• Holter & Event Monitoring Wearable monitors that track heart rhythm over time to diagnose irregular heartbeats, palpitations, dizziness, or unexplained symptoms. For patients with suspected intermittent arrhythmias.
• Nuclear Cardiology Advanced imaging that shows blood flow to the heart muscle to identify areas of reduced circulation and guide treatment decisions. For patients with suspected coronary artery disease.
• Vascular Ultrasound Imaging service to evaluate blood flow and vessel health. For patients with suspected peripheral vascular disease or carotid disease.
• Calcium Score Testing Diagnostic test to assess calcium buildup in coronary arteries. For patients seeking cardiovascular risk assessment.
• Cardiac PET/CT Advanced imaging combining positron emission tomography and computed tomography for detailed heart assessment. For patients requiring advanced myocardial perfusion or viability evaluation.
• Coronary CT Arteriography Non-invasive imaging of coronary arteries using CT technology. For patients needing visualization of coronary anatomy without invasive catheterization.
• Cardiovascular Disease Prevention Personalized risk assessment and preventive strategies with early intervention to significantly reduce the risk of heart attack and stroke. For at-risk adults seeking proactive heart health management.
• Hypertension & Cholesterol Management Ongoing evaluation and treatment of high blood pressure and cholesterol levels. For patients with chronic cardiovascular risk factors requiring long-term management.
• Pacemaker Follow-Up Care Long-term monitoring and management of pacemaker devices. For patients with implanted cardiac devices requiring periodic interrogation and adjustment.
• Left Heart Catheterization Invasive procedure to evaluate and diagnose left heart and coronary artery conditions. For patients with suspected significant coronary artery disease requiring definitive anatomical assessment.
• Eastern Shore Research Institute (ESRI) Clinical Trials Clinical research division conducting Phase I-IV clinical trials across cardiovascular conditions, connecting patients with innovative treatments and contributing to medical publications. For pharmaceutical sponsors seeking trial sites and patients seeking access to investigational therapies.
• 30-Second Clinical Trial Screening Online pre-screening tool that collects medical history to determine potential eligibility for clinical trials. For prospective clinical trial participants in the Eastern Shore region.

Quantifiable outcome

• Same-day and next-day appointments available
• +1 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Thomas HospitalcoreStrategic or Co-development PartnerPrimary hospital affiliation for inpatient cardiology services. Dr. Harris is specifically affiliated with Thomas Hospital. The practice provides 24-hour coverage at the hospital for cardiology consultations and emergency care.
• AstraZenecaminorOthersPharmaceutical sponsor for multiple clinical trials including AZURE D7960C00015, PACIFIC D6972C00002, and BalanceD-HF. Trials focus on cholesterol management, hypertension with kidney disease, and heart failure.
• AmgenminorOthersPharmaceutical sponsor for OCEAN(a) trial targeting patients with elevated Lp(a) and MARITIME-CV cardiovascular outcomes study.
• PfizerminorOthersSponsor of GARDEN-TIMI 74 Phase II trial investigating prosegromab for heart failure symptoms and function.
• RegeneronminorOthersSponsor of ROXI-ATLAS trial for patients with atrial fibrillation/flutter who are willing to take anticoagulant therapy.
• Boehringer IngelheimminorOthersSponsor of EASi-PROTKT trial for patients with Type 2 Diabetes, Hypertension, and history of Cardiovascular Disease without Heart Failure.
• Novo NordiskminorOthersSponsor of HERMES trial for Heart Failure with Preserved Ejection Fraction with elevated inflammatory markers.
• DalCor PharmaceuticalsminorOthersSponsor of Dal-GenE-2 trial for patients who experienced myocardial infarction within the past 90 days.
• CytokineticsminorOthersSponsor of AMBER HFpEF trial for patients ages 40-85 with Heart Failure with Preserved Ejection Fraction >60%.
• New Amsterdam PharmaminorOthersCo-sponsor with Bayer of PREVAIL Phase III trial evaluating obicetrapib for ASCVD patients not adequately controlled on lipid-modifying therapies.
• BayerminorOthersCo-sponsor with New Amsterdam of PREVAIL Phase III trial for cardiovascular outcomes with obicetrapib.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Others

• Privia Health: Physician-enablement platform supporting independent practices with technology, payor relationships, and population health tools — a relevant comparator for an independent cardiology practice evaluating infrastructure partners.
• Javara: Integrated clinical research organization that embeds trial operations into independent physician practices — directly comparable to Heart Group's Eastern Shore Research Institute (ESRI) model.

Broad incumbents

• UAB Medicine Cardiovascular Institute: Academic cardiovascular institute in Alabama combining clinical cardiology, advanced imaging, and a high-volume clinical trials program — the dominant in-state cardiology referral destination.
• Sanger Heart & Vascular Institute (Atrium Health): Large hospital-affiliated cardiology and vascular program within a major health system, offering a comparable mix of consultative cardiology, imaging, and clinical research.
• Piedmont Heart Institute: Multi-site cardiology and cardiovascular surgery service line operated by Piedmont Healthcare; comparable in offering a comprehensive cardiology practice with imaging, prevention, and clinical trials under one umbrella.
• Cardiovascular Associates of America (CVAUSA): PE-backed aggregator that acquires and partners with independent cardiology practices across the U.S. Highly comparable as a consolidator of single-specialty cardiology groups with embedded diagnostic services.
• Norton Heart & Vascular Institute: Health-system cardiology service line providing general and interventional cardiology plus cardiac imaging; comparable as an integrated cardiology program with regional reach.

Direct peers

• Mobile Heart Specialists: Independent multi-physician cardiology practice in Mobile, Alabama — same regional market and same independent-practice model, with multi-modality non-invasive cardiac imaging.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/heartgroupeasternshore
• LinkedInlinkedin.com/company/heart-group-of-the-eastern-shore-p.c.

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heart Group of the Eastern Shore